Brian Ahrens

882 total citations
28 papers, 624 citations indexed

About

Brian Ahrens is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Molecular Biology. According to data from OpenAlex, Brian Ahrens has authored 28 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Cell Biology and 7 papers in Molecular Biology. Recurrent topics in Brian Ahrens's work include Hormonal and reproductive studies (19 papers), Muscle metabolism and nutrition (10 papers) and Pharmacological Effects and Assays (6 papers). Brian Ahrens is often cited by papers focused on Hormonal and reproductive studies (19 papers), Muscle metabolism and nutrition (10 papers) and Pharmacological Effects and Assays (6 papers). Brian Ahrens collaborates with scholars based in United States, Germany and United Kingdom. Brian Ahrens's co-authors include Don H. Catlin, Borislav Starcevic, Caroline K. Hatton, Yu‐Chen Chang, Tim Sobolevsky, Costas Georgakopoulos, Yu‐Chen Chang, Anthony W. Butch, Benjamin Z. Leder and Joel S. Finkelstein and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and Journal of Organometallic Chemistry.

In The Last Decade

Brian Ahrens

28 papers receiving 588 citations

Peers

Brian Ahrens
Carine Schweizer Switzerland
Gerd Sigmund Germany
Catrin Goebel Australia
Thomas Bassindale United Kingdom
Andrew Hutt United Kingdom
Oliver Krug Germany
Brian Ahrens
Citations per year, relative to Brian Ahrens Brian Ahrens (= 1×) peers Gregor Fußhöller

Countries citing papers authored by Brian Ahrens

Since Specialization
Citations

This map shows the geographic impact of Brian Ahrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Ahrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Ahrens more than expected).

Fields of papers citing papers by Brian Ahrens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Ahrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Ahrens. The network helps show where Brian Ahrens may publish in the future.

Co-authorship network of co-authors of Brian Ahrens

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Ahrens. A scholar is included among the top collaborators of Brian Ahrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Ahrens. Brian Ahrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobolevsky, Tim, Matthew Fedoruk, Frank Dellanna, et al.. (2024). Long‐Term Excretion of Roxadustat in Urine. Drug Testing and Analysis. 17(7). 1088–1092. 2 indexed citations
2.
Sobolevsky, Tim, Katja Walpurgis, Matthew Fedoruk, et al.. (2023). Detection of capromorelin in urine following oral and dermal routes of administration. Drug Testing and Analysis. 15(11-12). 1449–1453. 4 indexed citations
3.
Sobolevsky, Tim, et al.. (2023). Detection of selective androgen receptor modulator YK‐11 in a doping control sample. Drug Testing and Analysis. 16(6). 655–660. 3 indexed citations
4.
Sobolevsky, Tim, et al.. (2023). A Suspected Case of Carbon Monoxide Poisoning Consistent with Fentanyl Toxicity. The Journal of Applied Laboratory Medicine. 8(2). 413–417. 2 indexed citations
5.
Sobolevsky, Tim, Thomas Piper, Brian Ahrens, & Mario Thevis. (2022). AICAr to SAICAr ratio can serve as additional marker of AICAr use. Drug Testing and Analysis. 14(11-12). 2017–2025. 3 indexed citations
7.
Sobolevsky, Tim & Brian Ahrens. (2021). Biotin as a masking agent in chorionic gonadotropin assays utilizing biotinylated antibodies. Drug Testing and Analysis. 13(11-12). 1929–1935. 3 indexed citations
8.
Sobolevsky, Tim & Brian Ahrens. (2020). High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction. Drug Testing and Analysis. 13(2). 283–298. 18 indexed citations
9.
Cox, Holly D., Jessica O. Becker, Andreas Thomas, et al.. (2020). Inter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry. Clinical Chemistry. 66(4). 579–586. 24 indexed citations
10.
Sobolevsky, Tim, et al.. (2018). Isotopically labeled boldenone as a better marker of derivatization efficiency for improved quality control in anti‐doping analysis. Drug Testing and Analysis. 11(2). 336–340. 2 indexed citations
11.
Sobolevsky, Tim & Brian Ahrens. (2018). Urinary concentrations of AICAR and mannitol in athlete population. Drug Testing and Analysis. 11(3). 530–535. 6 indexed citations
12.
Butch, Anthony W., Brian Ahrens, & Nuraly K. Avliyakulov. (2017). Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction–tandem mass spectrometry to detect hCG use. Drug Testing and Analysis. 10(6). 956–960. 9 indexed citations
13.
14.
Ahrens, Brian, Borislav Starcevic, & Anthony W. Butch. (2012). Detection of Prohibited Substances by Liquid Chromatography Tandem Mass Spectrometry for Sports Doping Control. Methods in molecular biology. 902. 115–128. 17 indexed citations
15.
Green, Gary, et al.. (2009). The Influence of Diet on Isotope Ratio Mass Spectrometry Values. Clinical Journal of Sport Medicine. 19(4). 287–292. 8 indexed citations
16.
Ahrens, Brian, et al.. (2005). Another designer steroid: discovery, synthesis, and detection of ‘madol’ in urine. Rapid Communications in Mass Spectrometry. 19(6). 781–784. 103 indexed citations
17.
Catlin, Don H., et al.. (2004). Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Communications in Mass Spectrometry. 18(12). 1245–1049. 194 indexed citations
18.
Catlin, Don H., et al.. (2002). Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Communications in Mass Spectrometry. 16(13). 1273–1275. 103 indexed citations
19.
Catlin, Don H., Benjamin Z. Leder, Brian Ahrens, Caroline K. Hatton, & Joel S. Finkelstein. (2002). Effects of androstenedione administration on epitestosterone metabolism in men. Steroids. 67(7). 559–564. 23 indexed citations
20.
Ahrens, Brian, et al.. (1995). Screening and identification of sumatriptan and its main metabolite by means of thin-layer chromatography, ultraviolet spectroscopy and gas chromatography/mass spectrometry.. PubMed. 45(9). 941–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026